Bobbie Graham

1.9k total citations · 1 hit paper
24 papers, 1.0k citations indexed

About

Bobbie Graham is a scholar working on Infectious Diseases, Virology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Bobbie Graham has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 12 papers in Virology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Bobbie Graham's work include HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (12 papers) and HIV/AIDS Research and Interventions (9 papers). Bobbie Graham is often cited by papers focused on HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (12 papers) and HIV/AIDS Research and Interventions (9 papers). Bobbie Graham collaborates with scholars based in United States, Thailand and Belgium. Bobbie Graham's co-authors include Katherine Luzuriaga, Stephen A. Spector, William T. Shearer, Mobeen H. Rathore, Diane W. Wara, Ram Yogev, Susan Plaeger, Rebecca Oyomopito, Rebecca Gelman and Elizabeth J. McFarland and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Journal of Allergy and Clinical Immunology.

In The Last Decade

Bobbie Graham

24 papers receiving 992 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lymphocyte subsets in healthy children from birth through 18 years of age

2003 560 citations William T. Shearer, Howard M. Rosenblatt et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bobbie Graham United States	13	440	372	314	206	97	24	1.0k
Viviana Moschese Italy	19	311 0.7×	459 1.2×	372 1.2×	189 0.9×	47 0.5×	63	1.1k
M Stegagno Italy	13	384 0.9×	400 1.1×	281 0.9×	506 2.5×	168 1.7×	24	1.4k
Christina M. Lalama United States	17	765 1.7×	188 0.5×	862 2.7×	178 0.9×	194 2.0×	36	1.2k
Elizabeth Taylor Canada	14	169 0.4×	563 1.5×	401 1.3×	277 1.3×	78 0.8×	22	1.4k
Sonnie Kim United States	16	294 0.7×	394 1.1×	226 0.7×	394 1.9×	99 1.0×	24	1.5k
P. B. A. Kernoff United Kingdom	23	477 1.1×	211 0.6×	427 1.4×	506 2.5×	126 1.3×	75	2.3k
Tzong‐Hae Lee United States	13	429 1.0×	196 0.5×	505 1.6×	230 1.1×	107 1.1×	18	914
Andrea Gingelmaier Germany	19	301 0.7×	64 0.2×	116 0.4×	293 1.4×	79 0.8×	59	1.0k
Anna E. Coghill United States	23	214 0.5×	115 0.3×	61 0.2×	558 2.7×	81 0.8×	83	1.8k
Valeria Micheli Italy	20	577 1.3×	148 0.4×	390 1.2×	397 1.9×	33 0.3×	80	1.7k

Countries citing papers authored by Bobbie Graham

Since Specialization

Citations

This map shows the geographic impact of Bobbie Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bobbie Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bobbie Graham more than expected).

Fields of papers citing papers by Bobbie Graham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bobbie Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bobbie Graham. The network helps show where Bobbie Graham may publish in the future.

Co-authorship network of co-authors of Bobbie Graham

This figure shows the co-authorship network connecting the top 25 collaborators of Bobbie Graham. A scholar is included among the top collaborators of Bobbie Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bobbie Graham. Bobbie Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

MacBrayne, Christine E., Richard M. Rutstein, Andrew Wiznia, et al.. (2021). Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age. AIDS. 35(9). 1413–1421. 2 indexed citations

Clarke, Diana F., Edward P. Acosta, Jiajia Wang, et al.. (2020). Impact of Low Birth Weight and Prematurity on Neonatal Raltegravir Pharmacokinetics: Impaact P1097. JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(5). 626–634. 1 indexed citations

Krogstad, Paul, Pearl Samson, Edward P. Acosta, et al.. (2020). Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis. Journal of the Pediatric Infectious Diseases Society. 10(2). 201–204. 7 indexed citations

Paul, Mary E., Yanling Huo, Suad Kapetanovic, et al.. (2019). Sertraline Pharmacokinetics in HIV-Infected and Uninfected Children, Adolescents, and Young Adults. Frontiers in Pediatrics. 7. 16–16. 4 indexed citations

Huang, Liusheng, Vincent J. Carey, Jane C. Lindsey, et al.. (2017). Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children. PLoS ONE. 12(10). e0186589–e0186589. 4 indexed citations

Foca, Marc, Ram Yogev, Andrew Wiznia, et al.. (2016). Rilpivirine Pharmacokinetics Without and With Darunavir/Ritonavir Once Daily in Adolescents and Young Adults. The Pediatric Infectious Disease Journal. 35(9). e271–e274. 6 indexed citations

Cressey, Tim R., Rohan Hazra, Andrew Wiznia, et al.. (2016). Pharmacokinetics of Unboosted Atazanavir in Treatment-experienced HIV-infected Children, Adolescents and Young Adults. The Pediatric Infectious Disease Journal. 35(12). 1333–1335. 2 indexed citations

Rizk, Matthew L., Lihong Du, Larissa Wenning, et al.. (2015). Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV‐infected children 4 weeks to 18 years of age. The Journal of Clinical Pharmacology. 55(7). 748–756. 13 indexed citations

Nachman, Sharon, Edward P. Acosta, Hedy Teppler, et al.. (2015). Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age. Journal of the Pediatric Infectious Diseases Society. 4(4). e76–e83. 24 indexed citations

10.

Larson, Kajal, Tim R. Cressey, Ram Yogev, et al.. (2015). Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young Adults. Journal of the Pediatric Infectious Diseases Society. 5(2). 131–137. 8 indexed citations

11.

Rutstein, Richard M., Pearl Samson, Terry Fenton, et al.. (2014). Long-term Safety and Efficacy of Atazanavir-based Therapy in HIV-infected Infants, Children and Adolescents. The Pediatric Infectious Disease Journal. 34(2). 162–167. 13 indexed citations

12.

Kiser, Jennifer J., Richard M. Rutstein, Pearl Samson, et al.. (2011). Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents. AIDS. 25(12). 1489–1496. 17 indexed citations

13.

Gaur, Aditya H., Marvin Belzer, Paula Britto, et al.. (2010). Directly Observed Therapy (DOT) for Nonadherent HIV-Infected Youth: Lessons Learned, Challenges Ahead. AIDS Research and Human Retroviruses. 26(9). 947–953. 23 indexed citations

14.

Garvie, Patricia A., Patricia M. Flynn, Marvin Belzer, et al.. (2010). Psychological Factors, Beliefs About Medication, and Adherence of Youth With Human Immunodeficiency Virus in a Multisite Directly Observed Therapy Pilot Study. Journal of Adolescent Health. 48(6). 637–640. 18 indexed citations

15.

King, Jennifer R., Edward P. Acosta, Ram Yogev, et al.. (2009). STEADY-STATE PHARMACOKINETICS OF LOPINAVIR/RITONAVIR IN COMBINATION WITH EFAVIRENZ IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PEDIATRIC PATIENTS. The Pediatric Infectious Disease Journal. 28(2). 159–161. 6 indexed citations

16.

Luzuriaga, Katherine, Margaret McManus, Lynne Mofenson, et al.. (2004). A Trial of Three Antiretroviral Regimens in HIV-1–Infected Children. New England Journal of Medicine. 350(24). 2471–2480. 106 indexed citations

17.

Shearer, William T., Howard M. Rosenblatt, Rebecca Gelman, et al.. (2003). Lymphocyte subsets in healthy children from birth through 18 years of age. Journal of Allergy and Clinical Immunology. 112(5). 973–980. 560 indexed citations breakdown →

18.

Capparelli, Edmund V., John L. Sullivan, Lynne Mofenson, et al.. (2001). Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants. The Pediatric Infectious Disease Journal. 20(8). 746–751. 30 indexed citations

19.

Shearer, William T., Robert J. Israel, Stuart E. Starr, et al.. (2000). Recombinant CD4‐IgG2 in Human Immunodeficiency Virus Type 1–Infected Children: Phase 1/2 Study. The Journal of Infectious Diseases. 182(6). 1774–1779. 61 indexed citations

20.

Broder, S, et al.. (1994). HIV interaction with sperm [letter]. AIDS. 8(12). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact